Functionalised biomaterials as synthetic extracellular matrices to promote vascularisation and healing of diabetic wounds

Cell Tissue Res. 2024 Feb;395(2):133-145. doi: 10.1007/s00441-023-03849-4. Epub 2023 Dec 5.

Abstract

Diabetic foot ulcers (DFU) are a type of chronic wound that constitute one of the most serious and debilitating complications associated with diabetes. The lack of clinically efficacious treatments to treat these recalcitrant wounds can lead to amputations for those worst affected. Biomaterial-based approaches offer great hope in this regard, as they provide a template for cell infiltration and tissue repair. However, there is an additional need to treat the underlying pathophysiology of DFUs, in particular insufficient vascularization of the wound which significantly hampers healing. Thus, the addition of pro-angiogenic moieties to biomaterials is a promising strategy to promote the healing of DFUs and other chronic wounds. In this review, we discuss the potential of biomaterials as treatments for DFU and the approaches that can be taken to functionalise these biomaterials such that they promote vascularisation and wound healing in pre-clinical models.

Keywords: Biomaterials; Diabetic foot ulcers; Vascularisation.

Publication types

  • Review

MeSH terms

  • Biocompatible Materials / pharmacology
  • Biocompatible Materials / therapeutic use
  • Diabetes Mellitus*
  • Diabetic Foot* / drug therapy
  • Extracellular Matrix
  • Humans
  • Wound Healing

Substances

  • Biocompatible Materials